AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 160 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,018,000 | -78.5% | 67,310 | -89.3% | 0.02% | -85.5% |
Q2 2022 | $4,736,000 | +93.4% | 631,490 | +134.7% | 0.13% | +101.5% |
Q1 2022 | $2,449,000 | -7.3% | 269,110 | -28.5% | 0.06% | -20.7% |
Q4 2021 | $2,642,000 | -15.1% | 376,323 | +37.8% | 0.08% | -6.8% |
Q3 2021 | $3,113,000 | +196.2% | 273,064 | +251.0% | 0.09% | +25.7% |
Q4 2020 | $1,051,000 | +373.4% | 77,800 | +745.7% | 0.07% | +400.0% |
Q4 2019 | $222,000 | -73.7% | 9,200 | -79.0% | 0.01% | -72.5% |
Q3 2019 | $844,000 | +158.9% | 43,900 | +299.0% | 0.05% | +41.7% |
Q2 2019 | $326,000 | – | 11,003 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |